Year |
Citation |
Score |
2023 |
Jacobsen LM, Diggins K, Blanchfield L, McNichols JA, Perry DJ, Brant J, Dong X, Bacher R, Gersuk VH, Schatz DA, Atkinson MA, Mathews CE, Haller MJ, Long SA, Linsley PS, et al. Responders to low-dose ATG induce CD4 T cell exhaustion in type 1 diabetes. Jci Insight. PMID 37432736 DOI: 10.1172/jci.insight.161812 |
0.339 |
|
2022 |
Yang JHM, Ward-Hartstonge KA, Perry DJ, Blanchfield JL, Posgai AL, Wiedeman AE, Diggins K, Rahman A, Tree TIM, Brusko TM, Levings MK, James EA, Kent SC, Speake C, Homann D, et al. Guidelines for standardizing T-cell cytometry assays to link biomarkers, mechanisms, and disease outcomes in type 1 diabetes. European Journal of Immunology. 52: 372-388. PMID 35025103 DOI: 10.1002/eji.202049067 |
0.307 |
|
2021 |
Armitage LH, Stimpson SE, Santostefano KE, Sui L, Ogundare S, Newby BN, Castro-Gutierrez R, Huber MK, Taylor JP, Sharma P, Radichev IA, Perry DJ, Fredette NC, Savinov AY, Wallet MA, et al. Use of Induced Pluripotent Stem Cells to Build Isogenic Systems and Investigate Type 1 Diabetes. Frontiers in Endocrinology. 12: 737276. PMID 34858326 DOI: 10.3389/fendo.2021.737276 |
0.341 |
|
2021 |
Perry DJ, Peters LD, Lakshmi PS, Zhang L, Han Z, Wasserfall CH, Mathews CE, Atkinson MA, Brusko TM. Overexpression of the Autoimmune Risk Variant LYP-620W Fails to Restrain Human CD4 T Cell Activation. Journal of Immunology (Baltimore, Md. : 1950). PMID 34301848 DOI: 10.4049/jimmunol.2000708 |
0.384 |
|
2020 |
Motwani K, Peters LD, Vliegen WH, El-Sayed AG, Seay HR, Lopez MC, Baker HV, Posgai AL, Brusko MA, Perry DJ, Bacher R, Larkin J, Haller MJ, Brusko TM. Human Regulatory T Cells From Umbilical Cord Blood Display Increased Repertoire Diversity and Lineage Stability Relative to Adult Peripheral Blood. Frontiers in Immunology. 11: 611. PMID 32351504 DOI: 10.3389/Fimmu.2020.00611 |
0.417 |
|
2020 |
Dean JW, Peters LD, Fuhrman CA, Seay HR, Posgai AL, Stimpson SE, Brusko MA, Perry DJ, Yeh WI, Newby BN, Haller MJ, Muir AB, Atkinson MA, Mathews CE, Brusko TM. Innate inflammation drives NK cell activation to impair Treg activity. Journal of Autoimmunity. 102417. PMID 32035746 DOI: 10.1016/J.Jaut.2020.102417 |
0.381 |
|
2020 |
Beam CA, Wasserfall C, Woodwyk A, Akers M, Rauch H, Blok T, Mason P, Vos D, Perry D, Brusko T, Peakman M, Atkinson M. Synchronization of the Normal Human Peripheral Immune System: A Comprehensive Circadian Systems Immunology Analysis. Scientific Reports. 10: 672. PMID 31959869 DOI: 10.1038/S41598-019-56951-5 |
0.355 |
|
2018 |
Jacobsen LM, Newby BN, Perry DJ, Posgai AL, Haller MJ, Brusko TM. Immune Mechanisms and Pathways Targeted in Type 1 Diabetes. Current Diabetes Reports. 18: 90. PMID 30168021 DOI: 10.1007/S11892-018-1066-5 |
0.339 |
|
2018 |
Perry DJ, Wasserfall CH, Oram RA, Williams MD, Posgai A, Muir AB, Haller MJ, Schatz DA, Wallet MA, Mathews CE, Atkinson MA, Brusko TM. Application of a Genetic Risk Score to Racially Diverse Type 1 Diabetes Populations Demonstrates the Need for Diversity in Risk-Modeling. Scientific Reports. 8: 4529. PMID 29540798 DOI: 10.1038/S41598-018-22574-5 |
0.317 |
|
2018 |
CAMARGO A, PERRY DJ, BRUSKO TM, WALLET MA. SH2B3 (lnk) Regulates Type 1 Diabetes Immune Phenotypes Diabetes. 67: 224-LB. DOI: 10.2337/Db18-224-Lb |
0.339 |
|
2018 |
ROSS JJ, WASSERFALL C, PERRY DJ, MCGRAIL KM, POSGAI AL, BRUSKO TM, SCHATZ D, HALLER MJ, ATKINSON MA. Exocrine Pancreatic Function as a Novel Biomarker in Pre-T1D Diabetes. 67: 1543-P. DOI: 10.2337/Db18-1543-P |
0.33 |
|
2017 |
Chen J, Chernatynskaya AV, Li JW, Kimbrell MR, Cassidy RJ, Perry DJ, Muir AB, Atkinson MA, Brusko TM, Mathews CE. T cells display mitochondria hyperpolarization in human type 1 diabetes. Scientific Reports. 7: 10835. PMID 28883439 DOI: 10.1038/S41598-017-11056-9 |
0.427 |
|
2017 |
Marcial GE, Ford AL, Haller MJ, Gezan SA, Harrison NA, Cai D, Meyer JL, Perry DJ, Atkinson MA, Wasserfall CH, Garrett T, Gonzalez CF, Brusko TM, Dahl WJ, Lorca GL. Lactobacillus johnsonii N6.2 Modulates the Host Immune Responses: A Double-Blind, Randomized Trial in Healthy Adults. Frontiers in Immunology. 8: 655. PMID 28659913 DOI: 10.3389/Fimmu.2017.00655 |
0.344 |
|
2016 |
Lowe JR, Perry DJ, Salama AK, Mathews CE, Moss LG, Hanks BA. Genetic risk analysis of a patient with fulminant autoimmune type 1 diabetes mellitus secondary to combination ipilimumab and nivolumab immunotherapy. Journal For Immunotherapy of Cancer. 4: 89. PMID 28031819 DOI: 10.1186/S40425-016-0196-Z |
0.331 |
|
2016 |
Haller MJ, Gitelman SE, Gottlieb PA, Michels AW, Perry DJ, Schultz AR, Hulme MA, Shuster JJ, Zou B, Wasserfall CH, Posgai A, Mathews CE, Brusko TM, Atkinson MA, Schatz DA. Anti-Thymocyte Globulin + G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders with Established Type 1 Diabetes. Diabetes. PMID 27669730 DOI: 10.2337/Db16-0823 |
0.394 |
|
2015 |
Fuhrman CA, Yeh WI, Seay HR, Saikumar Lakshmi P, Chopra G, Zhang L, Perry DJ, McClymont SA, Yadav M, Lopez MC, Baker HV, Zhang Y, Li Y, Whitley M, von Schack D, et al. Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226. Journal of Immunology (Baltimore, Md. : 1950). 195: 145-55. PMID 25994968 DOI: 10.4049/Jimmunol.1402381 |
0.404 |
|
2015 |
Yin Y, Choi SC, Xu Z, Perry DJ, Seay H, Croker BP, Sobel ES, Brusko TM, Morel L. Normalization of CD4+ T cell metabolism reverses lupus. Science Translational Medicine. 7: 274ra18. PMID 25673763 DOI: 10.1126/Scitranslmed.Aaa0835 |
0.405 |
|
2012 |
Thompson JA, Perry D, Brusko TM. Autologous regulatory T cells for the treatment of type 1 diabetes. Current Diabetes Reports. 12: 623-32. PMID 22843491 DOI: 10.1007/S11892-012-0304-5 |
0.428 |
|
2012 |
Perry DJ, Yin Y, Telarico T, Baker HV, Dozmorov I, Perl A, Morel L. Murine lupus susceptibility locus Sle1c2 mediates CD4+ T cell activation and maps to estrogen-related receptor γ. Journal of Immunology (Baltimore, Md. : 1950). 189: 793-803. PMID 22711888 DOI: 10.4049/Jimmunol.1200411 |
0.432 |
|
2011 |
Perry D, Peck AB, Carcamo WC, Morel L, Nguyen CQ. The current concept of T (h) 17 cells and their expanding role in systemic lupus erythematosus. Arthritis. 2011: 810649. PMID 22164330 DOI: 10.1155/2011/810649 |
0.39 |
|
2011 |
Xu Z, Potula HH, Vallurupalli A, Perry D, Baker H, Croker BP, Dozmorov I, Morel L. Cyclin-dependent kinase inhibitor Cdkn2c regulates B cell homeostasis and function in the NZM2410-derived murine lupus susceptibility locus Sle2c1. Journal of Immunology (Baltimore, Md. : 1950). 186: 6673-82. PMID 21543644 DOI: 10.4049/Jimmunol.1002544 |
0.352 |
|
2007 |
Rahman ZS, Niu H, Perry D, Wakeland E, Manser T, Morel L. Expression of the autoimmune Fcgr2b NZW allele fails to be upregulated in germinal center B cells and is associated with increased IgG production. Genes and Immunity. 8: 604-12. PMID 17713556 DOI: 10.1038/Sj.Gene.6364423 |
0.332 |
|
2005 |
Chen Y, Perry D, Boackle SA, Sobel ES, Molina H, Croker BP, Morel L. Several genes contribute to the production of autoreactive B and T cells in the murine lupus susceptibility locus Sle1c. Journal of Immunology (Baltimore, Md. : 1950). 175: 1080-9. PMID 16002709 DOI: 10.4049/Jimmunol.175.2.1080 |
0.425 |
|
Show low-probability matches. |